TFA
FBIO icon

Toth Financial Advisory’s Fortress Biotech FBIO Stock Holding History

Toth Financial Advisory’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-400
Closed -$1.48K – 950
2025
Q3 		$1.48K Buy
+400
New +$1.01K ﹤0.01% 724

Other funds holding FBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Summit Financial
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Sculptor Capital
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bridgeway Capital Management
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Toth Financial Advisory's FBIO Position: Q4 2025 in Review

Toth Financial Advisory sold out of Fortress Biotech (FBIO) in Q4 2025, closing a stake of 400 shares — an estimated $1.48K sold.

Toth Financial Advisory first reported a position in FBIO in Q3 2025 and held it in 1 quarter. The position peaked at $1.48K in Q3 2025. 52 funds tracked by Wall St. Rank hold FBIO as of Q4 2025.

  • Toth Financial Advisory reported no remaining Fortress Biotech position as of Q4 2025 after selling out during the quarter.
  • Toth Financial Advisory sold 400 Fortress Biotech shares in Q4 2025, an estimated $1.48K.
  • Toth Financial Advisory first reported a position in Fortress Biotech in Q3 2025 and held it in 1 quarter.
  • Toth Financial Advisory's Fortress Biotech position peaked at $1.48K in Q3 2025.
  • 52 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2025.

Based on Toth Financial Advisory's 13F filing for Q4 2025, filed 20 Jan 2026.